# COVID Supplement B Cell Epitope Discovery and Mechanisms of Antibody Protection.

> **NIH NIH N01** · WASHINGTON UNIVERSITY · 2020 · $1,810,144

## Abstract

This contract supports the identification of human B cell epitopes derived from viral pathogens; such as Coronavirus, Dengue virus 4, Powassan virus, Chikungunya virus, and Venezuelan equine encephalitis virus, combined with basic studies to understand protective immunity mediated by antibodies, as well as pathological consequences of antibody responses.

## Key facts

- **NIH application ID:** 10285431
- **Project number:** 75N93019C00062-P00003-9999-2
- **Recipient organization:** WASHINGTON UNIVERSITY
- **Principal Investigator:** —
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,810,144
- **Award type:** —
- **Project period:** 2019-09-16 → 2022-03-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10285431

## Citation

> US National Institutes of Health, RePORTER application 10285431, COVID Supplement B Cell Epitope Discovery and Mechanisms of Antibody Protection. (75N93019C00062-P00003-9999-2). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10285431. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*